MK-8521
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MK-8521, covering 2018-03-08 to 2022-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003) [Phase 1]